摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-O-(benzoyl)-1,6-anhydro-3,4-dideoxy-β-D-erythro-hex-3-enopyranose | 67307-86-2

中文名称
——
中文别名
——
英文名称
2-O-(benzoyl)-1,6-anhydro-3,4-dideoxy-β-D-erythro-hex-3-enopyranose
英文别名
1,6-anhydro-2-O-benzoyl-3,4-dideoxy-β-D-erythro-hex-3-enopyranose;1,6-anhydro-3,4-dideoxy-2-O-(benzoyl)-beta-D-erythro-hex-3-enopyranose;[(1S,4R,5R)-6,8-dioxabicyclo[3.2.1]oct-2-en-4-yl] benzoate
2-O-(benzoyl)-1,6-anhydro-3,4-dideoxy-β-D-erythro-hex-3-enopyranose化学式
CAS
67307-86-2
化学式
C13H12O4
mdl
——
分子量
232.236
InChiKey
PCUIWYHIKRMCJR-DMDPSCGWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    348.5±42.0 °C(Predicted)
  • 密度:
    1.30±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-O-(benzoyl)-1,6-anhydro-3,4-dideoxy-β-D-erythro-hex-3-enopyranosepotassium carbonate 作用下, 以 甲醇 为溶剂, 反应 1.5h, 以98.6%的产率得到1,6-anhydro-3,4-dideoxy-β-D-erythro-hex-3-enopyranose
    参考文献:
    名称:
    Synthesis of D-Allosan from Levoglucosenone
    摘要:
    The stereoselective reduction and cis-dihydroxylation of levoglucosenone (1,6-anhydro-3,4-dideoxy-beta-D-glycero-hex-3-enopyranos-2-ulose), gave D-allosan (1,6-anhydro-beta-D-allopyranose) in high yield.
    DOI:
    10.3987/com-91-5872
  • 作为产物:
    描述:
    左旋葡萄糖酮 、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium tetrahydroborate 、 三苯基膦偶氮二甲酸二乙酯 作用下, 以 四氢呋喃 为溶剂, 反应 48.17h, 生成 2-O-(benzoyl)-1,6-anhydro-3,4-dideoxy-β-D-erythro-hex-3-enopyranose
    参考文献:
    名称:
    Synthesis of Methylene-Expanded 2‘,3‘-Dideoxyribonucleosides
    摘要:
    A method for the preparation of methylene-expanded 2',3'-dideoxyribonucleosides is reported. The very inexpensive starting material levoglucosenone 8 was converted into the known mixture of alcohols 12ab which were converted into the required silyl ether alcohol 26 in six steps via either of two routes. The first involved a one-step acetylation and opening of the anhydro sugar bridge to give the triacetates 20ab which were reduced with triethylsilane and silyl triflate to afford the diacetates 21ab, both of which gave 26 after further functional group conversions. The second route entailed a simple acetylation of 12ab followed by reduction with triethylsilane and silyl triflate to give the monoacetates 19ab, both converted via straightforward chemistry into 26. Mesylation of the alcohol of 26 furnished the mesylate 27. Alkylation of adenine with the mesylate 27 afforded the silyl ether 28 which was deprotected to give the desired modified dideoxy nucleoside 7a. Alkylation of 2,6-diaminopurine 38 with the mesylate gave the protected diaminopurine nucleoside 39. Upon acetylation, it produced a mixture of di- and monoacetates 40-41, the latter of which was transformed into the desired guanosine analogue 7e. Thus, two new nucleoside analogues 7ae were prepared from levoglucosenone 8.
    DOI:
    10.1021/jo980436l
点击查看最新优质反应信息

文献信息

  • Method of manufacturing D-allosan
    申请人:Japan Tobacco Inc.
    公开号:US05457192A1
    公开(公告)日:1995-10-10
    The carbonyl group at the 2-position of levoglucosenone is reduced to obtain a hydroxyl group having a .beta.-configuration. The hydroxyl group having a .beta.-configuration is reversed to an .alpha.-configuration, and hydroxyl groups are added at the 3- and 4-positions in a cis-.alpha. form. Finally, the protective group of the hydroxyl group at the 2-position is eliminated. The reduction of the carbonyl group at the 2-position can be performed such that the levoglucosenone is reacted with aluminum lithium hydride or sodium boron hydride in an appropriate solvent. Reversion of the hydroxyl group having a .beta.-configuration can be performed by the Mitsunobu method or a method having a mesylation step and a step using cesium acetate. The addition of the hydroxyl groups to the 3-and 4-positions in the cis form can be performed by oxidizing the double bond across the 3- and 4-positions with an appropriate oxidizing agent. The elimination of the protective group of the hydroxyl group at the 2-position can be performed under basic conditions in accordance with normal methods. According to the method of the present invention, D-allosan can be obtained stereoselectively in high yield via a smaller number of steps than that of the conventional synthesis method.
    在得到一个具有β-构型的羟基团之后,对蔗糖醛酮的2位上的羰基团进行还原。将具有β-构型的羟基团转变为α-构型,然后以顺式α形式在3位和4位加入羟基团。最后,消除2位处羟基团的保护基团。对2位处羰基团的还原可以通过将蔗糖醛酮与适当溶剂中的铝锂氢化物或硼氢化钠反应来完成。具有β-构型的羟基团的转变可以通过Mitsunobu方法或包含甲磺酰化步骤和使用乙酸铯的方法来完成。以顺式形式在3位和4位加入羟基团可以通过适当的氧化剂氧化3位和4位之间的双键来完成。2位处羟基团的保护基团的消除可以根据常规方法在碱性条件下完成。根据本发明的方法,可以通过比传统合成方法更少的步骤高产率地立体选择性地获得D-阿洛三糖。
  • PROCESS FOR PRODUCING D-ALLOSAN
    申请人:Japan Tobacco Inc.
    公开号:EP0530367A1
    公开(公告)日:1993-03-10
    A process for producing D-allosan (IV) from levoglucosenone (I) in a high yield, which comprises reducing the 2-carbonyl group of levoglucosenone, inverting the configuration of the resultant hydroxyl group from α to β, protecting it by acylation to give a compound (III), conducting α-cis addition of two hydroxyl groups to the double bond of the compound (III), and removing the protective group.
    一种以左旋葡烯酮 (I) 为原料高产制备 D-allosan (IV) 的工艺,该工艺包括还原左旋葡烯酮的 2-羰基,将所得羟基的构型从 α 反转为 β,通过酰化作用对其进行保护,得到化合物 (III),将两个羟基与化合物 (III) 的双键进行 α-顺式加成,然后除去保护基。
  • US5457192A
    申请人:——
    公开号:US5457192A
    公开(公告)日:1995-10-10
  • Synthesis of D-Allosan from Levoglucosenone
    作者:Katsuya Matsumoto、Takashi Ebata、Koshi Koseki、Hiroshi Kawakami、Hajime Matsushita
    DOI:10.3987/com-91-5872
    日期:——
    The stereoselective reduction and cis-dihydroxylation of levoglucosenone (1,6-anhydro-3,4-dideoxy-beta-D-glycero-hex-3-enopyranos-2-ulose), gave D-allosan (1,6-anhydro-beta-D-allopyranose) in high yield.
  • Synthesis of Methylene-Expanded 2‘,3‘-Dideoxyribonucleosides
    作者:Michael E. Jung、Mehrak Kiankarimi
    DOI:10.1021/jo980436l
    日期:1998.11.1
    A method for the preparation of methylene-expanded 2',3'-dideoxyribonucleosides is reported. The very inexpensive starting material levoglucosenone 8 was converted into the known mixture of alcohols 12ab which were converted into the required silyl ether alcohol 26 in six steps via either of two routes. The first involved a one-step acetylation and opening of the anhydro sugar bridge to give the triacetates 20ab which were reduced with triethylsilane and silyl triflate to afford the diacetates 21ab, both of which gave 26 after further functional group conversions. The second route entailed a simple acetylation of 12ab followed by reduction with triethylsilane and silyl triflate to give the monoacetates 19ab, both converted via straightforward chemistry into 26. Mesylation of the alcohol of 26 furnished the mesylate 27. Alkylation of adenine with the mesylate 27 afforded the silyl ether 28 which was deprotected to give the desired modified dideoxy nucleoside 7a. Alkylation of 2,6-diaminopurine 38 with the mesylate gave the protected diaminopurine nucleoside 39. Upon acetylation, it produced a mixture of di- and monoacetates 40-41, the latter of which was transformed into the desired guanosine analogue 7e. Thus, two new nucleoside analogues 7ae were prepared from levoglucosenone 8.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐